| Ronald D Schlabach, MD | |
|
937 Highway 64 E, Alma, AR 72921-7382 | |
| (479) 632-3855 | |
| (479) 632-0356 |
| Full Name | Ronald D Schlabach |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 937 Highway 64 E, Alma, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831184837 | NPI | - | NPPES |
| 100202540A | Medicaid | OK | |
| 115770001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | N7592 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health - Fort Smith | Fort smith, AR | Hospital |
| Baptist Health - Van Buren | Van buren, AR | Hospital |
| Mercy Hospital Fort Smith | Fort smith, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Regional Hospitals | 0244589612 | 3 |
| Fands Physical Therapy, Inc | 7810898459 | 88 |
News Archive
Employees in the smallest firms (1-9 workers) pay an average 18% more in health insurance premiums than those in the largest firms (1,000+ workers), when actuarial value - the percentage of total medical expenses paid by a health plan - is taken into account, a new Commonwealth Fund-supported study finds.
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
A possibly important ally of the immune system that can help with the tricky task of separating friend from foe has been identified by scientists at Washington University School of Medicine in St. Louis.
› Verified 5 days ago
| Entity Name | Baptist Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922587690 PECOS PAC ID: 0648514133 Enrollment ID: O20181211001401 |
News Archive
Employees in the smallest firms (1-9 workers) pay an average 18% more in health insurance premiums than those in the largest firms (1,000+ workers), when actuarial value - the percentage of total medical expenses paid by a health plan - is taken into account, a new Commonwealth Fund-supported study finds.
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
A possibly important ally of the immune system that can help with the tricky task of separating friend from foe has been identified by scientists at Washington University School of Medicine in St. Louis.
› Verified 5 days ago
| Entity Name | Baptist Health Regional Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811606254 PECOS PAC ID: 0244589612 Enrollment ID: O20230220000306 |
News Archive
Employees in the smallest firms (1-9 workers) pay an average 18% more in health insurance premiums than those in the largest firms (1,000+ workers), when actuarial value - the percentage of total medical expenses paid by a health plan - is taken into account, a new Commonwealth Fund-supported study finds.
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
A possibly important ally of the immune system that can help with the tricky task of separating friend from foe has been identified by scientists at Washington University School of Medicine in St. Louis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald D Schlabach, MD 11001 Executive Center Dr Ste 200, Little Rock, AR 72211-4393 Ph: (479) 632-3855 | Ronald D Schlabach, MD 937 Highway 64 E, Alma, AR 72921-7382 Ph: (479) 632-3855 |
News Archive
Employees in the smallest firms (1-9 workers) pay an average 18% more in health insurance premiums than those in the largest firms (1,000+ workers), when actuarial value - the percentage of total medical expenses paid by a health plan - is taken into account, a new Commonwealth Fund-supported study finds.
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
A possibly important ally of the immune system that can help with the tricky task of separating friend from foe has been identified by scientists at Washington University School of Medicine in St. Louis.
› Verified 5 days ago
Christopher B Bell, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 605 Heather Ln, Alma, AR 72921 Phone: 479-430-7587 Fax: 479-430-7582 | |
Kristina M Combs, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Highway 71 N, Alma, AR 72921 Phone: 479-632-6688 Fax: 479-632-0055 | |
Dr. Thanh Le, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 937 Highway 64 E, Alma, AR 72921 Phone: 479-632-3855 | |
Michael G Kemp, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 937 Highway 64 E, Alma, AR 72921 Phone: 479-632-3855 Fax: 479-709-7443 | |
Robert G Bishop, M. D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Highway 71 N, Alma, AR 72921 Phone: 479-632-6688 Fax: 479-632-0055 | |
Javed A Rana, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Highway 71 N, Alma, AR 72921 Phone: 479-632-6688 Fax: 479-632-0055 | |
Dr. Jeffrey A. Medlock, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 937 Highway 64 East, Alma, AR 72921 Phone: 479-632-3855 Fax: 479-632-0296 |